Enoxaparin in Children With Asymptomatic Venous Thrombosis After Pediatric Cardiac Surgery

Summary

The CATCH-enoxaparin trial is the natural continuation of the CATCH study. It will capitalize on the fact that patients enrolled in the CATCH study will be specifically screened for asymptomatic thromboembolism (TEs) in order to answer important clinical questions. The investigators propose a randomized controlled trial to address whether, among pediatric patients with congenital heart defects (CHD) recovering from cardiovascular surgery and diagnosed with an asymptomatic venous TE, the use of enoxaparin results in a net therapeutic benefit?

Timeline

Start

2011-08

Primary completion

2015-08

Completion

2015-08

Drugs

Indications